Author Archives: achicotel

About achicotel

Anthony Chicotel is a staff attorney for CANHR. His areas of expertise include the rights of long-term care residents, nursing home litigation, health care decision-making, and conservatorships.

Johnson and Johnson Ordered to Pay $1.2 Billion for Mis-marketing Risperdal

by Anthony Chicotel, CANHR Staff Attorney A judge recently ordered Johnson and Johnson to pay the state of Arkansas $1.2 billion for illegally marketing its antipsychotic drug Risperdal. The lawsuit included allegations that Johnson and Johnson illegally marketed Risperdal for … Continue reading

Share

The Kids Ain’t Alright

by Anthony Chicotel, CANHR Staff Attorney The National Center for Youth Law (NCYL) has announced a national project to stop the overuse of psychotropic medications on foster children.  CANHR recently met with the NCYL project leaders and we shared information … Continue reading

Share

DPH Collaborative Issues First Fine for Illegal Drugging

The California Department of Public Health’s (DPH) Antipsychotic Drug Collaborative has issued its first citation and monetary fine against a nursing home for illegally drugging residents with chemical restraints.  The citation was issued against Briarwood Health Care – a nursing home … Continue reading

Share

Nursing Home Group Calls for Reducing Antipsychotics

by Anthony Chicotel, CANHR Staff Attorney LeadingAge, an association of over 5,400 not-for-profit organizations including long-term care providers and aging services organizations, recently released a statement on antipsychotic drug use for dementia care.  The statement clearly expresses LeadingAge’s opposition to inappropriate … Continue reading

Share

Zyprexa, Haldol, lol

by Anthony Chicotel, CANHR Staff Atorney CANHR recently learned of a nurse who posted the following statement via social media: Someone is acting crazy.  I think one of my [patients] needs sum cocktail. Zyprexa or haldol or both bwahaha.  Wait … Continue reading

Share

Anti-Depressants Linked to Nursing Home Falls

A new study released by the British Journal of Clinical Pharmacology has found a significant relationship between anti-depressant use and injurious falls for nursing home residents with dementia.  The authors tracked 248 ambulatory residents with dementia for two years.  They … Continue reading

Share

Drugging in Canada

A December 2011 report from the British Columbia Ministry of Health has found that over 50% (50.3% to be exact) of all residents of “residential care facilities” are on antipsychotic drugs. That number represents a fairly significant rise from 37% … Continue reading

Share

Non-pharm to the MAKS

A study that comes from Germany has found that non-pharmacological therapies focused on exercise, rehabilitation, and psycho-social well-being can slow cognitive declines associated with dementia. The therapies were provided in four components or MAKS: Motor Stimulation (a.k.a. exercise), Activities of … Continue reading

Share

No Surprises: Chemical Restraints Sedate and Subdue the Elderly with Dementia

by Anthony Chicotel, CANHR Staff Attorney The recent release of an AHRQ (Agency for Healthcare Research and Quality) report on the off-label use of atypical antipsychotics has raised some eyebrows among advocates for the least medicating approach to dementia care. … Continue reading

Share

Some Post-Senate Hearing Scribbles

by Anthony Chicotel, CANHR Staff Attorney 1. Inappropriate use of antipsychotic drugs is finally receiving its due regard as a common and insidious form of elder abuse. The “Least Medicating” movement has made it to the U.S. Senate! 2. Senator … Continue reading

Share